arrow
C

Christian Datz

Medical University of Vienna
H指数:58
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk (vol 19, 101932, 2026)

酒精摄入重编程肝免疫-代谢回路以加剧小鼠动脉粥样硬化和人类心血管风险(vol 19, 101932, 2026)

2026-09-010
OA
PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis☆

PNPLA3和TM6SF2加剧了酒精和代谢功能障碍对肝纤维化的影响☆

2025-10-300
OAAI
Rheumatoid arthritis is independently associated with metabolic Dysfunction-Associated steatotic liver disease: evidence from the paracelsus 10,000 Population-Based cohort study

类风湿关节炎与代谢功能障碍相关脂肪性肝病独立相关:来自帕拉塞尔苏斯10,000人群队列研究的证据

2025-10-060
OA
Association between depression and metabolic dysfunction-associated steatotic liver disease: a cross-sectional analysis from the paracelsus 10,000 Study

抑郁与代谢功能障碍相关脂肪性肝病之间的关联:一项来自帕拉塞尔苏斯10,000研究的横断面分析

2025-10-010
OA
Austrian multisociety consensus on metabolic dysfunction-associated steatotic liver disease

奥地利多学会关于代谢功能障碍相关脂肪性肝病的共识

2025-10-010
OAAI
Prevalence of fibrosis and applicability of lab-based non-invasive tests from primary to tertiary care

纤维化患病率及实验室基础无创检测在初级至三级医疗中的适用性

2025-09-160
OAAI
Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization

丹吉尔病的脂质失调: 病例系列和代谢特征

2025-03-010
OA
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

关于使用国际疾病分类代码治疗代谢功能障碍相关脂肪肝疾病的全球调查

2024-06-159
PRE